Lucinda Quan
Founder bij ALIGOS THERAPEUTICS, INC.
Vermogen: 314 770 $ op 30-04-2024
Momenteel actieve connecties
| Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
|---|---|---|---|---|
| Lawrence Blatt | M | 62 |
Alios BioPharma, Inc.
 Alios BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Alios BioPharma, Inc. operates as a clinical stage biopharmaceutical company which develops novel antiviral therapies for the treatment of respiratory diseases. It also develops proprietary chemical libraries of novel nucleosides, nucleoside analogs and non-nucleosides as potential therapeutics for viral infections including RSV, influenza, rhinovirus and emerging viral diseases. The firm offers VX-135, a uridine nucleotide analog for the treatment of chronic hepatitis C. The company was founded by Leonid N. Beigelman, Lawrence M. Blatt and John R. Donovan in 2008 and is headquartered in San Francisco, CA. | 19 jaar |
| Jack Nielsen | M | 60 |
Alios BioPharma, Inc.
Alios BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Alios BioPharma, Inc. operates as a clinical stage biopharmaceutical company which develops novel antiviral therapies for the treatment of respiratory diseases. It also develops proprietary chemical libraries of novel nucleosides, nucleoside analogs and non-nucleosides as potential therapeutics for viral infections including RSV, influenza, rhinovirus and emerging viral diseases. The firm offers VX-135, a uridine nucleotide analog for the treatment of chronic hepatitis C. The company was founded by Leonid N. Beigelman, Lawrence M. Blatt and John R. Donovan in 2008 and is headquartered in San Francisco, CA. | 13 jaar |
| Inge Thulin | M | 69 | 6 jaar | |
| Jordyn Tarazi | F | - | - | |
| Bridget Martell | M | 58 | 3 jaar | |
| Jennifer Zachary | F | 46 | 6 jaar | |
| Jim Scopa | M | 65 | 3 jaar | |
| K. Hirth | M | 72 | 6 jaar | |
| Carole Nüchterlein | F | 63 | 6 jaar | |
| Dean Li | M | 62 | 7 jaar | |
| Lesley Calhoun | F | 58 | 4 jaar | |
| Eric Rubin | M | 65 | 6 jaar | |
| Peter Dannenbaum | M | - | 7 jaar | |
| Carla Fiankan | F | - | 13 jaar | |
| Julian Symons | M | 63 | 6 jaar | |
| Matthew McClure | M | 53 | 5 jaar | |
| Sushmita M. Chanda | M | 58 | 6 jaar | |
| Kristina Engeseth | F | - | - |
Relatiegrafiek
Connectie in verschillende bedrijven
Oude connecties
| Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
|---|---|---|---|---|
| Leonid Beigelman | M | 66 |
Alios BioPharma, Inc.
Alios BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Alios BioPharma, Inc. operates as a clinical stage biopharmaceutical company which develops novel antiviral therapies for the treatment of respiratory diseases. It also develops proprietary chemical libraries of novel nucleosides, nucleoside analogs and non-nucleosides as potential therapeutics for viral infections including RSV, influenza, rhinovirus and emerging viral diseases. The firm offers VX-135, a uridine nucleotide analog for the treatment of chronic hepatitis C. The company was founded by Leonid N. Beigelman, Lawrence M. Blatt and John R. Donovan in 2008 and is headquartered in San Francisco, CA. | 15 jaar |
| John C. Hodgman | M | 69 | - | |
| Jean-Jacques Bienaimé | M | 70 | 2 jaar | |
| Thomas Woiwode | M | 52 | 5 jaar | |
| Lars Ekman | M | 74 | 7 jaar | |
| Peter Moldt | M | 65 | - | |
| Frank Verwiel | M | 62 | 2 jaar | |
| Kathleen Glaub | F | 70 | - | |
| John Noseworthy | M | 71 | - | |
| Angus Russell | M | 68 | 3 jaar | |
| Jonathan Leff | M | 55 | 12 jaar | |
| David Kabakoff | M | 76 | 9 jaar | |
| Charles Kidder | M | 79 | 12 jaar | |
| Andrew Powell | M | 66 | 2 jaar | |
| Sheila Ranganath | F | - | 5 jaar | |
| Louis C. Drapeau | M | 79 | 7 jaar | |
| Paul D. Arata | M | 69 | - | |
| Natarajan Sethuraman | M | 62 | 10 jaar | |
| Ken Johnson | M | 61 | 1 jaar | |
| Daniel Pascheles | M | - | 11 jaar | |
| Roger Dansey | M | 68 | 3 jaar | |
| Joseph Eid | M | 56 | - | |
| Robert Plenge | M | 53 | 4 jaar | |
| Rongqiang Liu | M | 58 | 4 jaar | |
| Kimberly Park | F | 60 | 4 jaar | |
| Fariborz Kamal | M | 61 | 2 jaar | |
| Francesco Maria Lavino | M | 51 | 2 jaar | |
| Arthur Santora | M | 73 | 28 jaar | |
| Karen Akinsanya | M | 56 | 4 jaar | |
| Maria Rivas | M | 60 | 2 jaar | |
| Christopher Galloway | M | 53 | 2 jaar | |
| Yuan Xu | M | 56 | 2 jaar | |
| Reshma Rangwala | M | 46 | 5 jaar | |
| Carrie Krehlik | F | 56 | 3 jaar | |
| John Fry | M | - | 5 jaar | |
| Jay Galeota | M | 57 | 28 jaar | |
| John Renger | M | 55 | 15 jaar | |
| Marvin Johnson | M | 61 | 2 jaar | |
| Lisa LeCointe-Cephas | F | 42 | 6 jaar | |
| Joseph Arena | M | 69 | 1 jaar | |
| Elizabeth Ann Fagan | M | 74 | 4 jaar | |
| Srikanth Venkatraman | M | - | 4 jaar | |
| Soren Christiansen | M | 68 | 19 jaar | |
| Quentin Roach | M | 57 | 4 jaar | |
| Amy Klug | F | - | - | |
| Arnaub Chatterjee | M | - | 5 jaar | |
| Nancy Miller-Rich | F | 65 | 4 jaar | |
| Malcolm McKay | M | - | 4 jaar | |
| Le-Van Nguyen | F | - | 2 jaar | |
| Michael Holston | M | 61 | 6 jaar | |
| Roger L. Hawley | M | 71 | 3 jaar | |
| Steven Bryant Porter | M | 66 | 11 jaar | |
| Thomas Kassberg | M | 63 | 3 jaar | |
| Norman L. Halleen | M | 70 | 2 jaar | |
| Cynthia Y. Robinson | M | 65 | 3 jaar | |
| Willie Deese | M | 68 | 12 jaar | |
| Jonathan Leff | M | 66 | 3 jaar | |
| Alan Howard Cohen | M | 63 | - | |
| Sean Nolan | M | 56 | 2 jaar | |
| William Halter | M | 63 | 4 jaar | |
| Karen S. Wright | F | 69 | 2 jaar | |
| Heath Lukatch | M | 56 |
Alios BioPharma, Inc.
Alios BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Alios BioPharma, Inc. operates as a clinical stage biopharmaceutical company which develops novel antiviral therapies for the treatment of respiratory diseases. It also develops proprietary chemical libraries of novel nucleosides, nucleoside analogs and non-nucleosides as potential therapeutics for viral infections including RSV, influenza, rhinovirus and emerging viral diseases. The firm offers VX-135, a uridine nucleotide analog for the treatment of chronic hepatitis C. The company was founded by Leonid N. Beigelman, Lawrence M. Blatt and John R. Donovan in 2008 and is headquartered in San Francisco, CA. | 5 jaar |
| Michael Rosenblatt | M | 76 | 32 jaar | |
| Roy Baynes | M | 69 | - | |
| Bruce W. Tomlinson | M | 64 | 5 jaar | |
| Michel Vounatsos | M | 62 | 20 jaar | |
| Mathai Mammen | M | 57 | 1 jaar | |
| Mary Shoemaker | F | 63 | 1 jaar | |
| Barrett S. McGrath | M | - | - | |
| Erik Harris | M | 54 | 1 jaar | |
| Simon D. Kelner | M | 51 | 13 jaar | |
| Clark Golestani | M | 57 | 24 jaar | |
| Rosanne Roth | F | - | 2 jaar | |
| Steven Mizell | M | 64 | 8 jaar | |
| Phillip Samayoa | M | 37 | - | |
| Andrew Davis | M | 38 | 1 jaar | |
| Renu Vaish | F | - | 1 jaar | |
| Rick Modi | M | 55 | 2 jaar | |
| Thomas Cannell | M | 62 | 1 jaar | |
| Guy Patrick M. Eiferman | M | - | 4 jaar | |
| Jonathan Robbins | M | - | 6 jaar |
Statistieken
| Land | Connecties | % van het totaal |
|---|---|---|
| Verenigde Staten | 99 | 100.00% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- Lucinda Quan
- Persoonlijk netwerk
